J & J gets $2.1B offer to sell Lifescan glucometer business

Platinum Equity, a Los Angeles-based global investment firm focused on  mergers, acquisitions, and operations, has made a binding offer to acquire Johnson& Johnsons ' Chesterbrook, Pennsylvania and Zug, Switzerland-based LifeScan business, which sells the OneTouch line of connected and non-connected glucometers. Platinum Equity will pay $2.1 billion for the business, which reported $1.5 billion in net revenue last year.
Source: mobihealthnews - Category: Information Technology Source Type: news